Search This Blog

Friday, August 9, 2019

CASI Pharmaceuticals EPS misses by $0.07

CASI Pharmaceuticals (NASDAQ:CASI): Q2 GAAP EPS of -$0.16 misses by $0.07.
cash and equivalents of $70.3M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)